The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
May. 13, 2015
Applicant:
The Administrators of the Tulane Educational Fund, New Orleans, LA (US);
Inventors:
Robert F. Garry, New Orleans, LA (US);
Russell B. Wilson, Mandeville, LA (US);
Assignees:
The Administrators of the Tulane Educational Fund, New Orleans, LA (US);
Autoimmune Technologies, LLC, New Orleans, LA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 38/04 (2006.01); A61K 38/16 (2006.01); C07K 7/00 (2006.01); C07K 7/08 (2006.01); C12Q 1/18 (2006.01); C07K 7/06 (2006.01); G01N 33/569 (2006.01); C12N 7/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 38/04 (2013.01); A61K 38/162 (2013.01); C07K 7/00 (2013.01); C07K 7/08 (2013.01); C12N 7/00 (2013.01); C12Q 1/18 (2013.01); G01N 33/56988 (2013.01); A61K 38/00 (2013.01); C07K 7/06 (2013.01); C12N 2760/10022 (2013.01); C12N 2760/14122 (2013.01); C12N 2760/18422 (2013.01); C12N 2760/18433 (2013.01); C12N 2770/20022 (2013.01);
Abstract
The present invention provides compositions and methods for treating a measles virus infection. A pharmaceutical composition comprises a polypeptide in a biocompatible pharmaceutical carrier, in which the polypeptide consists of at least a portion of SEQ ID NO: 5 or SEQ ID NO: 6. A method embodiment comprises administering the polypeptide (preferably in a biocompatible pharmaceutical carrier) to a subject suffering from a measles infection.